Ferroptosis-IN-19, CAS [[3025114-13-7]]

Produktübersicht

• Artikelname: Ferroptosis-IN-19, CAS [[3025114-13-7]]
• Artikelnummer: MCE-HY-173313
• Hersteller Artikelnummer: HY-173313
• Alternativnummer: MCE-HY-173313-5MG,MCE-HY-173313-100MG,MCE-HY-173313-50MG,MCE-HY-173313-10MG,MCE-HY-173313-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Ferroptosis-IN-19 (compound C18) is a strong cellular ferroptosis inhibitor with an IC50 value of 0.097 µM. Ferroptosis-IN-19 shows high metabolic stability and favorable BBB permeability prediction. Ferroptosis-IN-19 has in vivo neuroprotection against ischemic brain injury in mice[1].

Produkteigenschaften

• Molekulargewicht: 355.86
• Reinheit: 98.92
• CAS Nummer: [3025114-13-7]
• Formel: C20H22ClN3O
• Target-Kategorie: Ferroptosis

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound